Versions Compared

Old Version 85

changes.mady.by.user Alex Pearce

Saved on

compared with

New Version 86

changes.mady.by.user Nicola Newton

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope 

Impact assessment of the estimands framework and recommendations/best practices (where applicable) for implementing the framework in the following areas:

  • Data Collect Design/CDASH
  • SDTM
  • ADaM (including handling of intercurrent events, missing data imputation) – Analysis Displays
  • cSDRG and ADRG

Development of new standards is not in scope, and any impact findings that may necessitate new standard development will be shared with CDISC for their consideration. Examples may be created on how to implement the framework by using permitted extensions to the existing data standards.



Project LeadsEmail
Chris Price, Roche

chris.price.cp1@roche.com

Lori VanMeter, Johnson & Johnsonlvanmet@ITS.JNJ.com
Nicola Newton, PHUSE Project Assistant

nicky@phuse.global


  • Completed public review of White Paper
  • Great interest in paper as received over 400 public comments
    • Collaborating

    Status
    colourBlue
    titleCURRENT STATUS
    Q1 2024

    Q2 2024

    • Continued collaborations with EIWG statisticians to align white paper White Paper recommendations.
    • Poster session at the US Connect and presentation at International Society for Biopharmaceutical Statistics (ISBS) 2024Presentation at CDISC 2024 Europe Interchange.




    Objectives & DeliverablesTimelines

    Submit abstracts for multiple conferences 

    		Q2 2023

    Develop draft White Paper for internal project review prior to PHUSE Working Group Review and Public Review

    		Q3 2023

     Final White Paper

    		Q1 2024